Controlling Health Care Costs Domestic Reference Pricing and Its Potential Role in Medicare Pharmaceutical Price Negotiations Explainer / Oct 26, 2021
Achieving Universal Coverage Agent Commissions in Medicare and the Impact on Beneficiary Choice Blog / Oct 12, 2021
Controlling Health Care Costs Medicare Patients Pay More for Drugs Than Older Adults in Other Countries; Congress Has an Opportunity to Move Forward Blog / Sep 30, 2021
Controlling Health Care Costs The Case for Drug-Pricing Reform — The Cost of Inaction Blog / May 26, 2021
Controlling Health Care Costs How Agents Influence Medicare Beneficiaries’ Plan Choices Fund Reports / Apr 21, 2021
Controlling Health Care Costs Prospects for Drug-Pricing Reform Under a Biden–Harris Administration Blog / Mar 23, 2021
Controlling Health Care Costs Catastrophic Coverage in the Medicare Part D Drug Benefit: Which Beneficiaries Need It and How Much Are They Spending? Issue Briefs / Sep 17, 2020
